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Center Groningen, Groningen, The NetherlandsObjectives. The aim of this study was to analyse the results of brachiocephalic fistulas for haemodialysis and to determine
possible predictors of failure.
Patients and methods. Between April 1999 and September 2004, a consecutive series of 100 autologous brachiocephalic
fistulas were created in 96 patients. There were 57 men and 39 women with a mean (SD) age of 59.2 (15.6) years. Data were
prospectively gathered.
Results. The mean (SD) follow-up was 20.1 (16.4) months. The primary, primary assisted, and secondary patency rates
after 6 months were 73.4, 83.2 and 86.4%, respectively. After 1 year, these figures were 54.7, 72.3 and 79.2%, and after 2
years 40.4, 59.2 and 67.5%, respectively. Predictors of failure with regard to primary patency, determined with Cox
regression multivariate analysis, included diabetes mellitus (HR 2.81, p!0.001) and a history of contralateral PTFE loop
graft (HR 7.79, pZ0.007).
Conclusion. Primary patency of brachiocephalic fistulas is comparable to that of radiocephalic fistulas. Primary assisted and
secondary patency rates can, however, be brought to a much higher level, especially in patients without diabetes and a large-
diameter venous outflow tract.Keywords: Brachiocephalic fistula; Gracz; Haemodialysis; Patency; Predictor; Diabetes.In 1997, the National Kidney Foundation—Dialysis
Outcome Quality Initiative (DOQI) initiated new
clinical practice guidelines aiming to give vascular
access decision-making an evidence-based character.1
One of the guidelines describes the order of preference
for the placement of arteriovenous fistulas. It is
thought that an autologous fistula performs better
than an allograft. The autologous radiocephalic lower-
arm fistula was selected as the fistula of choice because
of its long-term patency and low complication rate.2
Second choice according to the DOQI guidelines is the
brachiocephalic upper-arm fistula first described by
Cascardo et al. in 1970.3 The order of preference of
these surgical access procedures has been based on
several reports with varying patency rates. This raises
questions about the estimated patency rates for both
radiocephalic and brachiocephalic fistulas. Rooijens et
al.4 reported a meta-analysis of eight prospective andng author. Clark J. Zeebregts, MD, PhD, Division of
ery, Department of Surgery, University Medical Center
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las. The pooled estimated 1-year primary and second-
ary patency rates of 62.5% and 66.0%, respectively, is
disappointing. These relatively low patency rates may
be the result of the inclusion of patients with smaller
vessels, the elderly, women or diabetics. In certain
instances it may, therefore, be wise to choose the
brachiocephalic fistula as a first option for permanent
surgical access. In this study, we assessed the outcome
of a consecutive series of 100 brachiocephalic fistulas
and analysed the possible influence of patient-related
characteristics on success or failure.Patients and MethodsDesign of the study
This study is a prospective cohort analysis in a single-
centre university teaching hospital of patient related
factors influencing the outcome of primary autologous
brachiocephalic fistulas. Data were subtracted fromEur J Vasc Endovasc Surg 30, 209–214 (2005)
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characteristics, risk factors, anticoagulant medication,
co-morbidity according to the Society for Vascular
Surgery and the North American Chapter of the
International Society for Cardiovascular Surgery,5
intraoperative details, and postoperative complaints
and complications were all recorded. The influence of
these variables on primary, primary-assisted, and
secondary patency rate was assessed.Patient population and preoperative strategy
Between April 1999 and September 2004, a consecutive
series of 100 autologous brachiocephalic fistulas were
created in 96 patients. Four patients received a second
brachiocephalic fistula after occlusion of the contral-
ateral brachiocephalic fistula within the study period.
There were 57 male and 39 female patients with a
mean (SD) age of 59.2 (15.6) (range 21–82) years.
Concomitant co-morbidity included hypertension in
65 patients (68%), diabetes mellitus in 23 (24%), and
obesity (body mass index (BMI) R30 kg/m2) in 11
patients (11%). The causes of renal failure are listed in
Table 1.
To define the overall pool of patients undergoing
primary access surgery during the same period, data
regarding other access options were collected retro-
spectively from hospital records. In this time period, a
total of 129 radiocephalic fistulas in 117 patients (mean
age 58.9 (16.0)) and 60 polytetrafluoroethylene (PTFE)
grafts, including 55 loops and five straight grafts, in 52
patients (mean age 56.9 (14.5)) were carried out. In
addition, two autologous lower arm fistulas using the
ulnar artery and two autologous fistulas at the level of
the leg were performed. There were no statistical
differences with regard to mean age between these
various groups.
Preoperatively, both arms were examined with
duplex ultrasound scanning. Diameters of the brachial
artery and the cephalic vein at the levels of the elbow
and upper arm were determined. Duplex diameterTable 1. Causes of renal failure
Disease
Chronic renal failure, aetiology unknown
Primary glomerular diseases
Interstitial nephritis, pyelonephritis, drug-induced nephropathy and u
Cystic kidney diseases
Other congenital and hereditary kidney diseases
Renal vascular disease, excluding vasculitis
Diabetes mellitus
Other multisystem diseases
Others
Total
Eur J Vasc Endovasc Surg Vol 30, August 2005measurements took place with a cuff inflated up to
50 mmHg around the proximal upper arm. In
addition, the presence of central venous obstructions
was assessed. The minimum cephalic vein diameter
required was set at 2.5 mm. If technically possible, the
non-dominant extremity was used for construction of
the fistula.Timing
Maturation times of 1–4 months must elapse following
creation of an autologous fistula before it can be used.1
The fistula should, therefore, preferably be created
several months in advance of the anticipated need for
dialysis or an alternative temporary method of
vascular access must be used while the fistula
develops. As in most of our cases, a brachiocephalic
fistula was not the preferred first surgical procedure,
82% were already on dialysis at the time of operation.
At that moment, a total of 169 central venous lines had
been inserted. Although currently it is our policy to
use the internal jugular vein for temporary access in
most of the cases, 29 ipsilateral subclavian catheters
had been used in 22 patients, while 46 ipsilateral
jugular catheters had been inserted in 35 patients.
Thirty-five patients had a radiocephalic fistula created
previously on the ipsilateral side, while five of them
also had a PTFE loop graft on the same side.Surgical procedure
Operations were performed under general (58% of
cases), regional (39%) or local anaesthesia (3%). The
choice of anaesthesia was left to the anaesthetist’s and
patient’s preference. A transverse incision was made
in the cubital fossa and the median cubital vein, as well
as the cephalic and perforating veins, were explored.
An end-to-side anastomosis was made with a running
polypropylene 6-0 suture between the median cubital
vein and the brachial artery, as previously described
by Bender et al.6 The distal and perforating veinNo. of patients
10
18
rolithiasis 17
7
3
16
17
6
2
96
Brachiocephalic Haemodialysis Fistulas 211branches were ligated directing all flow towards the
upper arm cephalic vein. In some cases, an end-to-side
anastomosis between the cephalic vein and the
brachial artery was created. The length of the
anastomosis was chosen to fit the size of the vein,
usually 1.5–2 times the vein diameter. Fifty-nine
fistulas were created on the left and 41 on the right
side. Fistulas were allowed at least 6 weeks to develop
before puncture for haemodialysis.Follow up
Fistulas were checked for patency by clinical judge-
ment during regular visits at the dialysis centre three
times a week. Also, ultrasound dilution flow measure-
ments were performed with a Transonic HD01plus
Hemodialysis Monitor (Transonic Systems Inc., Ithaca,
NY, USA) on a monthly basis. In addition, Duplex
assessment (Sonoline Antares, Siemens Nederland
b.v., The Hague, The Netherlands) with a multi-
frequency probe (VFX 13-5) set at a frequency of
10 MHz was carried out on the day of discharge, and
after 3 and 6 months. Patients with repeatedly
measured flow rates of less than 600 ml/min or a
consistent decrease in time of 40% or more were
subjected to further analysis with angiography. Short
segment stenoses were subsequently treated with
percutaneous transluminal angioplasty (PTA).Definitions, endpoints, and statistics
Definitions of patency were those recommended by
the Committee on Reporting Standards for Arterio-
Venous Access of the Society for Vascular Surgery and
the American Association for Vascular Surgery.7 All
patency rates were calculated by means of Kaplan–
Meier analysis. Primary endpoints were defined as
thrombosis or occlusion of the fistula, inadequate
maturation, reintervention for assistance or restor-
ation of patency, change to another form of
dialysis, renal transplantation, or death of the
patient. The influence of 26 patient-related factors
was investigated by means of univariate analysis
with the use of Kaplan–Meier curves (log-rank
test). Continuous variables were transformed into
binary variables depending on their median. Vari-
ables that had a direct influence after univariate
analysis were entered in a stepwise backward
manner into a multivariate Cox regression model.
Significance was set at p!0.05. Data are presented
as means (SD), unless stated otherwise.ResultsPatency rates and mortality
Each patient was followed for at least 3 months. The
mean (SD) follow-up was 20.1 (16.4) (range 0.3–66.1)
months, including the early drop-outs. Reasons for
early failure within 4 months after the initial operation
included thrombosis (nZ3), immaturity (nZ5), steal
(nZ2), and untreatable stenosis (nZ1). Fistulas of all
these patients, including two patients who died with a
patent shunt, never came into use. Primary, primary
assisted, and secondary patency rates, as estimated by
means of Kaplan–Meier analysis, are outlined in Fig. 1.
Primary patency rates were 73.4, 54.7, and 40.4%, after
6 months, 1 and 2 years, respectively.
Primary assisted patency rates after 6 months, 1 and
2 years, were 83.2, 72.3, and 59.2%, respectively. A total
of 67 PTA procedures were carried out to maintain
fistula function in 28 patients. Fifteen patients had one
PTA, six patients had two, two patients had three, and
five patients had more than three PTA procedures, up
to 11 done in one single patient. In one patient, a
successful attempt was made to reduce flow because
of steal symptoms by placing a PTFE loop, while in
another patient flow was re-directed by ligation of the
basilic vein. Other flow reducing salvage procedures,
such as DRIL procedure or banding have not been
attempted in this study cohort, because of poor results
in the past.
Secondary patency rates were 86.4, 79.2, and 67.5%,
after 6 months, 1 and 2 years, respectively. A total of 15
surgical revision procedures were performed in 14
patients. All these 15 fistulas had thrombosed and
were treated with thrombectomy and subsequent
revision of a stenosis with a segment of saphenous
vein (nZ5) or excision of the stenosis with construc-
tion of a new anastomosis (nZ3), or interposition with
saphenous vein (nZ1) or PTFE (nZ6). With regard to
secondary patency, 29 fistulas were regarded as
permanent failures as secondary patency endpoints
were reached. Thirteen of these 29 fistulas had
occluded without (another) attempt to salvage the
fistula, six failed to mature and in 10 instances the use
of the brachiocephalic fistula was discontinued
because of steal syndrome (nZ4), venous hyperten-
sion (nZ2), fistula malfunction due to inability to
puncture appropriately (nZ2) or insufficient run-off
with untreatable central venous stenosis (nZ2).
Twenty-one patients died during the study period
for various reasons, mostly cardiac related and none of
them as the consequence of the primary operation.
One patient, however, died 2 h after a surgical revisionEur J Vasc Endovasc Surg Vol 30, August 2005
Fig. 1. Primary, primary assisted and secondary patency rates as estimated by Kaplan–Meier analysis.
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fibrillation.Predictors of failure with regard to primary patency
There were three variables that reached significance as
a predictor of failure with regard to primary patency at
univariate analysis, namely diabetes mellitus, a his-
tory of contralateral PTFE graft and thickness of the
suture (Table 2). These three variables were all entered
in a Cox regression multivariate analysis model.
Diabetes (HR 2.81, 95% CI 1.56–5.06, pZ0.0006) and
a history of contralateral PTFE (HR 7.79, 95% CI 1.75–
34.72, pZ0.007) were subsequently identified as
independent predictors of failure.Predictors of failure with regard to primary assisted patency
With regard to primary assisted patency, the same
variables were assessed (Table 2). Diabetes mellitus, a
history of ipsilateral jugular catheter, a history of
contralateral PTFE, and thickness of the suture were
identified as significant predictors of failure by
univariate analysis. These variables were entered in a
Cox regression model. Diabetes (HR 3.04, 95% CI 1.55–
5.96, pZ0.001), but also a history of contralateral PTFE
(HR 7.15, 95% CI 1.62–31.55, pZ0.009) and sutureEur J Vasc Endovasc Surg Vol 30, August 2005thickness (HR 5.58, 95% CI 1.64–18.90, pZ0.006) were
found to be independent predictors of failure.Predictors of failure with regard to secondary patency
With regard to secondary patency, again the same
variables were assessed (Table 2). Diabetes mellitus
and mean operation time of the initial procedure were
significant predictors of failure by univariate analysis.
These variables, as well as the mean diameter of the
cephalic vein at the level of the elbow (pZ0.095 by
univariate analysis), were entered in a Cox regression
model. Two factors could be identified as independent
predictors of failure, i.e. diabetes (HR 4.15, 95% CI
1.64–10.54, pZ0.003) and mean operation time (HR
1.03, 95% CI 1.01–1.04, pZ0.0002).Discussion
The 1-year primary and secondary patency rates of
54.7 and 79.2%, respectively, are in accordance with
the results of others.8–10 When compared with the
survival rate of radiocephalic fistulas, as reported in a
recent meta-analysis,4 primary patency of the brachio-
cephalic fistulas in the present study is lower (54.7
versus 62.5%), while secondary patency rates are better
(79.2 versus 66.0%). The figures mentioned in that
Table 2. Influence of various variables on patency rates as
calculated by univariate analysis with Kaplan–Meier curves (log
rank test)
Factor Patency
Primary, p Primary
assisted, p
Secondary, p
Sex 0.294 0.728 0.490
Mean age
(years)
0.781 0.658 0.971
Mean body
mass index
(BMI) (kg/m2)
0.505 0.298 0.161
Immunosup-
pressants
0.607 0.500 0.221
Diabetes mel-
litus
0.023 0.0009 0.0004
Hypertension 0.408 0.993 0.866
Preoperative
anticoagula-
tion
0.905 0.844 0.300
Preoperative
dialysis
0.265 0.405 0.499
Ipsilateral
subclavian
catheter
0.496 0.863 0.304
Contralateral
subclavian
catheter
0.804 0.253 0.347
Ipsilateral
jugular cath-
eter
0.348 0.013 0.306
Contralateral
jugular cath-
eter
0.946 0.577 0.371
Ipsilateral
RCF
0.311 0.428 0.470
Contralateral
RCF
0.800 0.645 0.371
Contralateral
BCF
0.590 0.962 0.645
Ipsilateral
PTFE loop
0.481 0.217 0.285
Contralateral
PTFE loop
0.015 0.026 0.521
Mean diam.
cephalic vein
upper arm
(mm)
0.299 0.398 0.306
Mean diam.
basilic vein
upper arm
(mm)
0.886 0.496 0.194
Mean diam.
cephalic vein
elbow (mm)
0.474 0.483 0.095
First operator 0.586 0.216 0.187
Fistula side 0.970 0.908 0.370
Anaesthesia 0.599 0.760 0.969
Suture thick-
ness
0.034 0.001 0.151
Mean oper-
ation time
(min)
0.182 0.126 0.025
Postoperative
anticoagula-
tion
0.476 0.370 0.577
RCF, radiocephalic fistula; BCF, brachiocephalic fistula; PTFE,
polytetrafluoroethylene; diam, diameter.
Brachiocephalic Haemodialysis Fistulas 213meta-analysis corroborate our previously reported
results with radiocephalic fistulas.11,12 With the aim
of achieving better patency rates, a nurse practitioner
especially dedicated to shunt care, a more meticulous
work-up with preoperative Duplex scanning in each
case, and the use of non-penetrating clips as a new
anastomosing technique were recently introduced in
our institution. Nevertheless, a careful selection of
patients for a radiocephalic or brachiocephalic fistula
seems of the utmost importance.
In the presented study cohort, the primary patency
of brachiocephalic fistulas is somewhat lower than
may be expected. Vessel sizes tend to be greater at the
level of the elbow, in comparison to the wrist, and
more easily accessible. On the other hand, steal
phenomena may occur more frequently with an
elbow fistula necessitating flow reducing salvage
procedures or ligation of the fistula. In addition, the
number of previously inserted central venous cath-
eters for temporary use is probably higher in the group
of patients with brachiocephalic fistulas, as this type of
fistula was only used if a radiocephalic fistula had
failed or was not feasible. However, by multivariate
analysis a previous history of either subclavian or
jugular catheters or ipsilateral radiocephalic fistulas
did not influence graft patency. In our institution,
35.7% of patients are dialysed through a radiocephalic
fistula, 30.1% through a brachiocephalic fistula, and
13.7% through a PTFE loop. The remaining patients
use jugular catheters (8.2% tunnelled and 12.3%
untunnelled, most of whom await further access
surgery). Other autologous options at the level of the
upper arm, though not performed in this study,
include either transposition of the basilic vein or the
distal cephalic vein.
Primary assisted and secondary patency rates in
this study are, in our opinion, quite reasonable and
compare favourably to those reported for radiocepha-
lic fistulas. With PTAs and surgical revisions one is
generally able to raise 1-year patency of radiocephalic
fistulas from 62.5 to 66.0%.4 In this study, revisions of
brachiocephalic fistulas resulted in a primary patency
of 54.7% compared to a secondary patency of 79.2%.
We believe that greater venous diameters results in
greater success after PTA and/or surgical revision. On
the other hand, fistulas that failed because of steal
syndrome may be associated with greater venous
diameters at the level of the elbow and the upper arm.
These parameters could, however, not be identified as
distinct predictors for the occurrence of steal
syndrome.
As previous radiocephalic fistulas do not influence
patency rates of brachiocephalic fistulas, we feel the
sequence of fistula operations should stay asEur J Vasc Endovasc Surg Vol 30, August 2005
C. J. Zeebregts et al.214recommended by the DOQI guidelines. Patients do
profit from radiocephalic fistulas, despite patency
rates that may be lower than expected, and vessels
are preserved for future accesses.
In this study, diabetes was found to have a negative
influence on primary, primary assisted and secondary
patency. The effect of diabetes may be even more
prominent in radiocephalic fistulas, as demonstrated
in several reports, including our previous study.11,13,14
Diabetes affects peripheral arteries, such as the radial
and ulnar artery, through medial sclerosis and
endothelial cell dysfunction with subsequent impaired
vasodilatation and hence stenosis.15 From this study it
appears that elbow sites are also affected by the same
pathological mechanisms. In contrast, Murphy et al.10
found no detrimental effect of diabetes on patency and
complication rates in a series of 293 elbow fistulas. In
their retrospective study, however, the diabetic group
included a significant lower proportion of women and
the numbers at risk had dropped considerably after 2
years of follow-up. The diabetic group in our study
population had a significant higher BMI than the non-
diabetic group (26.4 (5.4) versus 23.8 (3.6)). In the USA,
controversy about the detrimental effects of diabetes
had led to the preferential use of PTFE prostheses as
the initial choice of permanent access in diabetics.16
Although we have not investigated the results of PTFE
loops in diabetics in the present study, there are
several other reports suggesting that autologous
fistulas perform better than PTFE loops.17,18 From the
present study, it appears that PTAs and surgical
revisions are less successful in diabetics. Patients
with diabetes had smaller upper arm cephalic veins
(4.2 versus 3.9 mm), but these two factors were not
correlated with each other (pZ0.446), and the exist-
ence of a smaller venous outflow tract in itself was also
identified to be an independent factor for failure with
regard to secondary patency.
In conclusion, brachiocephalic fistulas seem to be a
good alternative to radiocephalic fistulas with primary
patency rates that are similar. Moreover, with brachio-
cephalic fistulas primary assisted and secondary
patency rates are more favourable than reported for
radiocephalic fistulas.Acknowledgements
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